Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatinLaura Poupon, Jérôme Busserolles, Sylvain Lamoine et al.|Neuropharmacology|2018Cited by 70
New Insight in Cold Pain: Role of Ion Channels, Modulation, and Clinical PerspectivesStéphane Lolignier, Jérôme Busserolles, Jacques Noël et al.|Journal of Neuroscience|2016Cited by 69
Chemotherapy-Induced Peripheral Neuropathy and New Therapeutic Targets: Preclinical Data of Drug RepositioningDavid Balayssac, Jérôme Busserolles, E. Wersinger et al.|Douleur et Analgésie|2022Cited by 0